Publication:
Immature platelet fraction: Is a novel early predictive marker for disease severity in patients with Covid-19 pneumonia?

dc.contributor.coauthorTasdemir, Z.A.
dc.contributor.coauthorPalaoğlu, K.E.
dc.contributor.departmentN/A
dc.contributor.kuauthorİncir, Said
dc.contributor.kuauthorKomesli, Zeynep
dc.contributor.kuauthorBaygül, Arzu Eden
dc.contributor.kuauthorÇaltı, Hatice Kant
dc.contributor.kuauthorKapmaz, Mahir
dc.contributor.kuauthorTekin, Süda
dc.contributor.kuauthorKılıç, Alparslan
dc.contributor.kuauthorDağel, Tuncay
dc.contributor.kuauthorOkan, Ayşe
dc.contributor.kuauthorSomay, Kayra
dc.contributor.kuauthorAkpınar, Timur Selçuk
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileFaculty Member
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.unitKoç University Hospital
dc.contributor.unitKoç University Hospital
dc.contributor.unitN/A
dc.contributor.unitKoç University Hospital
dc.contributor.unitKoç University Hospital
dc.contributor.unitKoç University Hospital
dc.contributor.unitKoç University Hospital
dc.contributor.unitKoç University Hospital
dc.contributor.unitKoç University Hospital
dc.contributor.unitKoç University Hospital
dc.contributor.unitN/A
dc.contributor.yokid175430
dc.contributor.yokidN/A
dc.contributor.yokid272290
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokid42146
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokid216646
dc.date.accessioned2024-11-10T00:10:57Z
dc.date.issued2021
dc.description.abstractObjectives : In many diseases, immature platelet fraction (IPF%) is related to coagulopathy and poor outcome. This study aimed to investigate the predictive value of IPF% for the severity of pneumonia in patients with Coronavirus Disease 2019 (COVID-19). Methods : A total of 154 patients with COVID‐19 infections were included. The patients were divided into two groups according to the severity of pneumonia (severe and non-severe) regarding their oxygen demand. Results : Given laboratory parameters, the median IPF% was significantly higher in the severe group (11.9 vs. 3.9%, p<0.001). Mean platelet volume (p<0.001), platelet-large cell ratio (p=0.001), platelet distribution width (p=0.001), D-Dimer (p<0.001), INR (p=0.003), and aPTT (p=0.007) were also found to be significantly higher in the severe group. Moreover, IPF (p=0.014, Odds ratio = 2.000, 95%CI: 1.149-3.482) was an independent predictor for the severity. The curve value from receiver operating characteristics was 0.879 (p<0.001, 95%CI: 0.784-0.943) for determining the severity of pneumonia. IPF% had a sensitivity and specificity value of 69.5 and 92.4% to detect the disease’s severity. Conclusions : IPF% is an independent predictor for the severity of COVID-19 pneumonia. Assessment of IPF% may both help to early determine high-risk patients with COVID-19 and to alert the physicians. / Amaç : Pek çok hastalıkta, immatür platelet fraksiyonu (%İPF), koagülopati ve kötü sonuçla ilişkilidir. Bu çalışma, Coronavirus Hastalığı 2019 (COVID-19) olan hastalarda pnömoni şiddeti için %İPF’nin prediktif değerini araştırmayı amaçladı. Yöntem : COVID-19 enfeksiyonu olan toplam 154 hasta dahil edildi. Hastalar, oksijen ihtiyaçları göz önüne alınarak pnömoni şiddetine göre (ağır ve ağır olmayan) iki gruba ayrıldı. Bulgular : Laboratuvar parametrelerine bakıldığında, medyan İPF yüzdesi ağır grupta anlamlı olarak daha yüksekti (%11.9′a karşı %3.9, p<0.001). Ortalama trombosit hacmi (p<0.001), trombosit-büyük hücre oranı (p=0.001), trombosit dağılım genişliği (p=0.001), D-Dimer (p<0.001), İNR (p=0.003) ve aPTT (p=0.007) ağır grupta anlamlı olarak daha yüksek bulundu. Ayrıca, İPF (p=0.014, Odds oranı = 2.000, %95 CI: 1.149-3.482) hastalık şiddeti için bağımsız bir öngördürücü olarak bulundu. Algılayıcı işletim eğrisinden gelen eğri değeri, pnömoni şiddetini belirlemek için 0.879 (p<0.001, %95 CI: 0.784-0.943) idi. İPF, hastalığın şiddetini saptamak için %69.5′lik duyarlılık ve %92.4′lük özgüllük değerine sahipti. Sonuç : İPF, COVID-19 pnömonisinin şiddeti için bağımsız bir öngörücüdür. %İPF’nin değerlendirilmesi, hem COVID-19′lu yüksek riskli hastaları erken belirlemeye hem de hekimleri uyarmaya yardımcı olabilir.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyTR Dizin
dc.description.issue4
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.volume46
dc.identifier.doi10.1515/TJB-2021-0070
dc.identifier.issn0250-4685
dc.identifier.linkhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85115384573&doi=10.1515%2fTJB-2021-0070&partnerID=40&md5=0c746ede4472bef38ffc2e89b857c9ca
dc.identifier.quartileQ4
dc.identifier.scopus2-s2.0-85115384573
dc.identifier.urihttps://doi.org/10.1515/tjb-2021-0070
dc.identifier.urihttps://hdl.handle.net/20.500.14288/17389
dc.identifier.wos693607700004
dc.keywordsBiomarker
dc.keywordsBlood cell count
dc.keywordsCovid-19
dc.keywordsImmature platelet fraction
dc.keywordsSars-Cov-2 / Biyobelirteç
dc.keywordsTam kan sayımı
dc.keywordsCovid-19
dc.keywordsİmmatür plaket fraksiyonu
dc.keywordsSars-Cov-2
dc.languageEnglish
dc.publisherDe Gruyter Open Ltd
dc.sourceTurkish Journal of Biochemistry-Turk Biyokimya Dergisi
dc.subjectCovid-19 coagulopathy
dc.subjectThrombocytopenia
dc.subjectPatients
dc.titleImmature platelet fraction: Is a novel early predictive marker for disease severity in patients with Covid-19 pneumonia?
dc.title.alternativeImmatür platelet fraksiyonu: covid-19 pnömonisi olan hastalarda hastalik şiddeti için yeni bir erken prediktif belirteç olabilir mi?
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0002-7700-7388
local.contributor.authorid0000-0002-4862-6251
local.contributor.authorid0000-0003-0392-6709
local.contributor.authorid0000-0002-4070-6097
local.contributor.authorid0000-0002-4115-3914
local.contributor.authorid0000-0001-9419-8713
local.contributor.authorid0000-0002-2308-197X
local.contributor.authorid0000-0002-1281-6571
local.contributor.authorid0000-0002-0085-735X
local.contributor.authorid0000-0001-5089-4653
local.contributor.authorid0000-0002-9591-4475
local.contributor.kuauthorİncir, Said
local.contributor.kuauthorKomesli, Zeynep
local.contributor.kuauthorBaygül, Arzu Eden
local.contributor.kuauthorÇaltı, Hatice Kant
local.contributor.kuauthorKapmaz, Mahir
local.contributor.kuauthorTekin, Süda
local.contributor.kuauthorKılıç, Alparslan
local.contributor.kuauthorDağel, Tuncay
local.contributor.kuauthorOkan, Ayşe
local.contributor.kuauthorSomay, Kayra
local.contributor.kuauthorAkpınar, Timur Selçuk

Files